Rentokil Initial Plc (GB:RTO)
LSE:RTO
Top Page
Rentokil Initial
(LSE:RTO)
Select Model
Select Model
Rating:65Neutral
Price Target:
503.00 p
▲(3.01% Upside)
Action:DowngradedDate:03/07/26
The score is driven primarily by solid financial performance (strong revenue growth, consistent free cash flow, and improved leverage) and supportive earnings guidance focused on efficiency-led margin expansion. This is partially offset by a relatively expensive valuation (high P/E), and mixed near-term technical momentum (negative MACD despite the broader uptrend).
Positive Factors
Recurring route-based model & cross-sell
Rentokil’s core route-based, recurring-contract model creates predictable revenue streams and high service frequency that support durable customer retention and cross-sell. Dense route coverage increases technician productivity and margin scalability, underpinning steady cash flow and resilience over 2–6 months.
Negative Factors
Large termite provisions and cash costs
Material termite provisions and recurring cash settlements create a structural liability that reduces free cash flow and increases earnings volatility. Persistent settlement costs can divert capital from growth investments and slow deleveraging progress, posing a lasting drag on financial flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring route-based model & cross-sell
Rentokil’s core route-based, recurring-contract model creates predictable revenue streams and high service frequency that support durable customer retention and cross-sell. Dense route coverage increases technician productivity and margin scalability, underpinning steady cash flow and resilience over 2–6 months.
Read all positive factors
Rentokil Initial (RTO) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£12.27B
Dividend Yield1.68%
Average Volume (3M)6.35M
Price to Earnings (P/E)31.7
Beta (1Y)0.87
Revenue Growth-1.58%
EPS Growth-34.64%
CountryUK
Employees68,485
SectorIndustrials
Sector Strength72
IndustrySpecialty Business Services
Share Statistics
EPS (TTM)0.10
Shares Outstanding2,526,039,800
10 Day Avg. Volume8,726,283
30 Day Avg. Volume6,351,505
Financial Highlights & Ratios
PEG Ratio1.90
Price to Book (P/B)2.76
Price to Sales (P/S)2.15
P/FCF Ratio19.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£516.36Price Target Upside5.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)0.29
Revenue Forecast (FY)£7.24B
Rentokil Initial Business Overview & Revenue Model
Company Description
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying an...
How the Company Makes Money
Rentokil Initial generates revenue primarily through its pest control and hygiene services. The company operates a subscription-based model for many of its services, which ensures a steady stream of recurring revenue from long-term contracts with ...
Rentokil Initial Earnings Call Summary
Earnings Call Date:Mar 05, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Jul 23, 2026
Earnings Call Sentiment Positive
The call balanced strong operational and financial progress — including revenue and profit growth, significant free cash flow improvement, improved North American KPIs (lead flow, retention), successful cost saves and rapid technology/AI adoption — against notable near-term challenges: a large increase in termite provisions and cash costs, ongoing transformation and central cost investments, FX headwinds and integration-related setbacks earlier in the transition. Management presented clear remedial actions and a credible roadmap (brand expansion, satellite branches, Branch 360, simplified pay approach and a $100m cost program) that underpin confidence in hitting margin and cash targets by 2027.Positive Updates
Group Revenue and Organic Growth
Group revenue increased 3.8% to $6.9bn with organic revenue growth of 2.6%; H2 revenues grew 4.5% with organic growth of 3.5%.
Negative Updates
Large Increase in Termite Provision
Termite provision increased by $201m in 2025 (additional $122m in H2 after $79m in H1); cash cost of settling claims was $95m in 2025 and expected to be similar in 2026; long-term inflation assumption increased from 2% to 3.2%.
Read all updates
Q4-2025 Updates
Positive
Negative
Group Revenue and Organic Growth
Group revenue increased 3.8% to $6.9bn with organic revenue growth of 2.6%; H2 revenues grew 4.5% with organic growth of 3.5%.
Read all positive updates
Company Guidance
The management guided to build on 2025’s base (group revenue $6.9bn, organic +2.6%; adjusted operating profit margin 15.5%; adjusted operating profit just over $1bn; adjusted EPS $0.2591; free cash flow $615m, +24.5% and 98% conversion; year‑end net debt $3.65bn, leverage 2.6x) by focusing on North America and efficiencies: a $100m cost‑reduction target (of which $25m was delivered in 2025) to help drive North America margins to above 20% by 2027, expanding to ~30 regional/local brands and increasing small local branches (guidance cited ~220 satellite branches), while preserving capex (~$196m run‑rate) and targeting bolt‑on M&A of ~ $200m in 2026; they expect similar one‑off/adjusting spend to 2025 (~$92m) and cash termite payments of about $95m in 2026, aim to sustain free cash flow conversion above 80%, and pursue leverage toward a 2.0–2.5x net‑debt/EBITDA range, all while citing operational momentum (lead flow +7% H2; residential lead flow +7.1% H2; Q4 jobs +5.6%; Q4 Pest Control organic +2.6%) and a proposed full‑year dividend of $0.1239 (+3%).Rentokil Initial Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
66
Positive
Cash Flow
71
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.24B | 5.44B | 5.38B | 3.71B | 2.95B |
| Gross Profit | 717.06M | 4.56B | 1.50B | 977.00M | 714.80M |
| EBITDA | 717.06M | 1.10B | 1.16B | 747.00M | 676.80M |
| Net Income | 356.63M | 307.00M | 381.00M | 232.00M | 263.00M |
Balance Sheet | |||||
| Total Assets | 10.73B | 10.55B | 11.13B | 11.92B | 4.32B |
| Cash, Cash Equivalents and Short-Term Investments | 1.73B | 911.00M | 1.56B | 2.09B | 597.90M |
| Total Debt | 4.56B | 4.11B | 4.73B | 5.40B | 1.93B |
| Total Liabilities | 6.65B | 6.33B | 7.04B | 7.82B | 3.06B |
| Stockholders Equity | 4.09B | 4.23B | 4.09B | 4.10B | 1.26B |
Cash Flow | |||||
| Free Cash Flow | 583.51M | 463.00M | 526.00M | 410.00M | 403.30M |
| Operating Cash Flow | 741.34M | 678.00M | 737.00M | 600.00M | 563.20M |
| Investing Cash Flow | 15.93M | -373.00M | -416.00M | -1.20B | -441.10M |
| Financing Cash Flow | 20.49M | -752.00M | -361.00M | 1.32B | -417.10M |
Rentokil Initial Technical Analysis
Positive
488.30
Price Trends
462.72
Positive
448.46
Positive
411.48
Positive
Market Momentum
3.42
Negative
61.33
Neutral
78.98
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:RTO, the sentiment is Positive. The current price of 488.3 is above the 20-day moving average (MA) of 470.82, above the 50-day MA of 462.72, and above the 200-day MA of 411.48, indicating a bullish trend. The MACD of 3.42 indicates Negative momentum. The RSI at 61.33 is Neutral, neither overbought nor oversold. The STOCH value of 78.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:RTO.
Rentokil Initial Risk Analysis
Rentokil Initial disclosed 27 risk factors in its most recent earnings report. Rentokil Initial reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Rentokil Initial Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.90B | 19.41 | 16.69% | 1.27% | 0.84% | -62.73% | |
76 Outperform | £2.18B | 13.52 | 20.41% | 2.58% | 11.42% | -17.18% | |
65 Neutral | £12.27B | 31.67 | 6.51% | 1.68% | -1.58% | -34.64% | |
65 Neutral | £5.74B | 21.21 | 31.07% | 3.44% | 1.14% | 17.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £487.27M | 5.91 | 13.04% | 3.18% | 6.55% | 18.44% | |
54 Neutral | £327.41M | 275.23 | 0.58% | 2.31% | 6.90% | 145.00% |
* Industrials Sector Average
GB:RTO
Rentokil Initial
488.30
170.43
53.62%
GB:ITRK
Intertek
3,736.00
-391.50
-9.49%
GB:JSG
Johnson Service
128.40
0.57
0.45%
GB:MTO
Mitie Group plc
173.20
60.56
53.76%
GB:RST
Restore
239.50
23.52
10.89%
GB:SRP
Serco Group plc
291.40
134.85
86.14%
Rentokil Initial Corporate Events
Business Operations and StrategyDividendsFinancial Disclosures
Rentokil Initial Lifts Cash Flow and Margins as North America Strategy Gains Traction
Positive
Mar 5, 2026
Rentokil Initial reported 2025 revenue of $6.91bn, up 3.8% at constant currency, with group organic revenue growth improving to 3.5% in the second half and adjusted operating profit rising 5.4% as cost discipline and efficiency measures took hold....
Executive/Board Changes
Rentokil Initial Launches Search for Successor to Long-Serving Chair Richard Solomons
Neutral
Mar 5, 2026
Rentokil Initial plc has announced that Board Chair Richard Solomons plans to retire once a successor is appointed, triggering a formal chair succession process at the London- and New York-listed services group. The search for a new chair is being...
Executive/Board ChangesRegulatory Filings and Compliance
Rentokil Initial CFO Joins Watches of Switzerland Board as Non-Executive Director
Neutral
Feb 19, 2026
Rentokil Initial has announced that its Chief Financial Officer, Paul Edgecliffe-Johnson, has been appointed as a Non-Executive Director to the Board of Watches of Switzerland Group PLC, which is listed on the London Stock Exchange. The move under...
Business Operations and StrategyDelistings and Listing Changes
Rentokil Initial to Redeem and Delist €500m Notes Ahead of Maturity
Positive
Feb 12, 2026
Rentokil Initial has announced the early redemption of its €500 million 0.875% senior unsecured guaranteed notes, originally due on 30 May 2026, with full repayment scheduled for 2 March 2026 at par plus accrued interest. Following redemptio...
Business Operations and StrategyExecutive/Board Changes
Rentokil Initial Names Mike Duffy as New Chief Executive to Lead Next Growth Phase
Positive
Jan 13, 2026
Rentokil Initial plc has appointed US executive Mike Duffy as its new Chief Executive and Executive Director, effective 16 March 2026, with a transition period beginning when he joins as CEO Designate on 16 February 2026. Duffy, who will be based ...
Regulatory Filings and Compliance
Rentokil Initial Discloses ADS Purchase by Trust Linked to Non-Executive Director
Neutral
Dec 19, 2025
Rentokil Initial plc disclosed that the Samuel J. Mitchell, Jr. Revocable Trust, a person closely associated with non-executive director Samuel Mitchell, purchased 30 American Depositary Shares of the company on 11 August 2025 at a price of $25.12...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.